Most people on Copaxone would probably prefer to inject it only 3 times a week instead of daily, and now it looks as if that will be possible, according to
this.
The article states that
Teva will seek to move as many as half of the patients taking daily Copaxone injections to the newer version, which would have patent protection until 2030, the company has said. ...
The new higher-dosage formulation will be available immediately for shipping to distribution outlets and patients should be able to get the therapy within days, Teva said.